Seattle Genetics (SGEN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Seattle Genetics (SGEN)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Steve Lokness who wrote (118)	12/8/2007 1:05:06 PM
From: Steve Lokness	of 161

Hmmm, no thoughts on press release huh? From the release; In February, Seattle Genetics received a $60 million upfront payment, and has the potential to receive milestone payments exceeding $800 million and escalating double-digit royalties starting in the mid-teens. San Francisco-based Genentech funds research, development, manufacturing and marketing costs, including reimbursing Seattle Genetics for its costs to conduct SGN-40 clinical trials and development activities Seems to me this 12 million is real money. No cost to SGEN as DNA picks up all of the cost and SGEN just gets more money to fund other programs. .....Sweet! steve

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next